Curriculum Vitae

LANCE L. GOOBERMAN, M.D., J.D., D.A.B.A.M.

One South Centre Street
Merchantville, New Jersey 08109
(856) 663-8811
(856) 912-3977 Cell
(856) 488-6380 Fax

Email: lgooberman@mac.com
Website: www.lancegooberman.com


PERSONAL

Date of Birth: August 1, 1951
Married: Three children
Bilingual: English & Spanish

EDUCATION

Pennsauken High School
Pennsauken, New Jersey
1966-1970
Findlay College
Findlay, Ohio
1970-1971
Rutgers University
Camden, New Jersey
1971
Camden County College
Blackwood, New Jersey
1972-1973
Autonomous University of Guadalajara
Guadalajara, Mexico
1973-1974
Autonomous University of Ciudad Juarez
Ciudad Juarez, Mexico
1974-1978
University of Texas at El Paso
El Paso, Texas
1977
Widener University School of Law
Wilmington, Delaware
2001 – 2004

INTERNSHIP AND RESIDENCY TRAINING

Wilmington Medical Center
Wilmington, Delaware
Rotating Internship 1979-1980
Cooper Hospital/University Medical Center March 1980-April 1982
Camden, New Jersey
Residency, Internal Medicine April 1983-July 1983

LICENSURE*

MEDICAL*

New Jersey 25MA03819100-Issued 1980
Pennsylvania MD-038545-L-Issued 1980
CDS-NJ D03066600
DEA BG9594412
DEA Suboxone Waiver XG9594412
Physician Approval to the New Jersey Medical Marijuana Program – March 2014

LAW

Admitted to the Bar of the Commonwealth of Pennsylvania 2005 – ID 201260
Admitted to the Bar of State of New Jersey – May 15, 2007 – ID 019032005


EMPLOYMENT HISTORY

Emergency Physician Associates
Emergency Room
West Jersey Health Systems
Voorhees, New Jersey April 1982 to April 1983
Cooper Hospital Pain Center
Cooper Hospital, University Medical Center
Camden, New Jersey
Medical Consultant May 1982 to April 1983
Private Practice
Internal Medicine 1982 to 1996
Addiction Medicine 1987 to June 2003
Forensic Addiction Medicine 1993 to June 2003
Merchantville, New Jersey
Lance L. Gooberman, M.D., P.C.
Addiction Medicine 1996 to June 2003
Forensic Addiction Medicine 1996 to June 2003
Merchantville, New Jersey
President
Breath Alcohol Testing, Inc.
Merchantville, New Jersey 1993 to 1995
Founder, President, Chief Medical Officer 1995 to May 2003
U.S. Detox, Inc.
Merchantville, New Jersey 1995 to June 2003
NaltrexZone L.L.C. May 2003 to present
Pellet Technologies L.L.C. January 1, 2009 – Present
Interlock Device of New Jersey L. L. C. January 1, 2009 – Present
Addiction and Detoxification Institute LLC June 1, 2005 – Present

* My medical licenses were suspended for five years, two years active and three years stayed, May 1, 2003 to May 1, 2008, as part of a settlement agreement with the New Jersey Board of Medical Examiners after a case that presented a number of difficult issues that required consideration of the proper role and limits of innovation and the weighing of the risks and benefits of a potentially beneficial procedure, rapid opiate detoxification (ROD). There were no findings of fact or conclusions of law.


HOSPITAL APPOINTMENTS & PRIVILEGES (1982-2003)

Cooper Hospital, University Medical Center Our Lady of Lourdes Medical Center
Camden, New Jersey Camden, New Jersey
Staff Physician Staff Physician
West Jersey Health Systems Underwood Memorial Hospital
Camden, Voorhees, Berlin & Marlton Division Woodbury, New Jersey
Staff Physician Staff Physician
Admitting Privileges-Detoxification Unit
Kennedy Health System
Cherry Hill, New Jersey
Staff Physician

FELLOWSHIPS

The American Society of Addiction Medicine 1999
American College of Legal Medicine (ACLM) Fellowship 2006

CERTIFICATIONS

Educational Commission for Foreign Medical Graduates 1979
American Society of Addiction Medicine 1990
National Draeger, Inc.Breathalyzer Operator Course 900/900A 1993
National Draeger, Inc.Breathalyzer Level I Trainer Instructor 1994
National Draeger, Inc.Breathalyzer 7410 Training. 1998
Draeger Safety Diagnostics Inc. Operator Training Coursefor the Draeger Alcotest 7110 MKIII-C Version NJ 3.11’s,analytical system, components and peripherals as well ashow to operate the instrument and perform a New Jerseyspecific breath test sequence. 20082012
Diplomat of the American Board of Addiction Medicine 2009
Axion Training Institute, Inc.Analytical Laboratories, Inc.Forensic Chromatography VIII: “Theory & Practice” 2012
Axion Training Institute, Inc.Analytical Laboratories, Inc.Forensic Drug Analysis II 2013

MEMBERSHIPS AND SOCIETIES
American Society of Addiction Medicine

American College of Legal Medicine

National College for DUI Defense

American Bar Association

New Jersey State Bar Association


CONTINUING EDUCATION Upon Request


TEACHING
“Effects of Alcohol on the Human Body” for the course Alcohol, Vehicles and the Law, Widener University School of Law, Wilmington, Delaware, Spring Semesters, 2000 – present.

“DWI-Alcohol and the Human Body” for the course Forensic Evidence, Widener University
School of Law, Wilmington, Delaware, Spring Semester, 2012, 2013


PRESENTATIONS

International

Lecturer: “Development in Rapid Opiate Detoxification Under General Anesthesia:
Experience with over 1,000 Patients in Four Countries;” 41st International Council on Alcohol & Addiction; International Institute, Cairo, Egypt, May 19, 1997

Lecturer: “Octreotide Prevents Diarrhea during Rapid Opiate Detoxification,” 41st International Council on Alcohol & Addictions; International Institute, Cairo, Egypt, May 19, 1997.

Lecturer: “Depo-Naltrexone Implants for Opiate Dependence: Clinical Experience, Plasma Levels, and Opiate Challenge, Results in over 200 Patients,” 41st International Council on Alcohol & Addictions; International Institute, Cairo, Egypt, May 19, 1997

Lecturer: “Naltrexone Implants” presented at the 4th International Stapleford Conference on Addiction Medicine at the Royal Society of Medicine, London, England, January 9, 1998.

Lecturer: “Drug Addiction-A Treatable Disease. New Treatments for Heroin Addiction” presented at the 1998 American Psychiatric Association Annual Conference, Toronto, Ontario, Canada, June 4, 1998.

Lecturer: “Opiate Reversal under General Anesthesia with Induction of Naltrexone Maintenance Therapy Utilizing Depo-Naltrexone Preparation” presented at the 10th European Congress of Anesthesiology, Frankford, Germany, July 3, 1998.

Lecturer: “The Outpatient ICU: An Ideal Setting for Rapid Opiate Detoxification” presented at the 23rd Australian and New Zealand Annual Scientific Meeting on Intensive Care, Adelaide, Australia, October 9, 1998.

Lecturer: “Naltrexone Pellets for Implantation” presented to Vilnius University, Vilnius, Lithuania, August 17, 2001.

Lecturer: “Naltrexone Pellets for Implantation” presented to Physicians and Pharmacists at the Detoxification Centre in Lisbon, Portugal, January 8, 2002.

Lecturer: “Development of Naltrexone Pellets” presented at the Wuhan International Naltrexone Depot Symposium 2007, Wuhan, China.

Lecturer: “Neuvas Opciones de Tratamiento” presented at Congreso Nacional De Pisquiatria
Guatemala City, Guatemala, August 18-20, 2010

PRESENTATIONS

National

Round table discussion with Governor-elect James Florio
“The Perils of Drug and Alcohol Addiction,” Trenton, New Jersey, January 15, 1990

Panel on “Safe Homes” Program: Representing the Field of Addiction Medicine
Bishop Eustace Preparatory School, Pennsauken, New Jersey, October 21, 1991

Chief Residents Conference
“Managed Care Protocol for Addictions” Cooper Hospital, University Medical Center
Camden, New Jersey, November 20, 1991

The Robyn Stevens Show, “Interview on Alcoholism,” Channel 13 TV,
Turnersville, New Jersey, January 26, 1993

Chief Rounds; Panel Discussion Participant: “Alcoholism and Alcoholic Cardiomyopathy” Cooper Hospital, University Medical Center, Camden, New Jersey, February 4, 1993

1993-1994 Internship Survival Lectures, “Alcohol/Narcotic Withdrawal,” Cooper Hospital,
University Medical Center, Camden, New Jersey, August 13, 1993

Critical Care Education Day for Nurses, “The Addicted Critically Ill Patient,” West Jersey
Health Systems, Camden, New Jersey, September 22, 1993

Lecture, “Rapid Opiate Detoxification,” sponsored by Ohmeda Pharmaceutical, New York City
New York, January 23, 1996

Paper Session, “Rapid Opiate Detoxification,” American Society of Addiction Medicine,
Atlanta, Georgia, April 19, 1996

Component Session, “Rapid Opiate Detoxification,” American Society of Addiction Medicine,
Atlanta, Georgia, April 20, 1996

Course Director, “Evaluating Outcome of Opiate Detoxification under General Anesthesia:
The Last 100 Years of Opiate Detoxification;” American Society of Addiction Medicine, 28th Annual Medical-Scientific Conference, San Diego, California, April 20, 1997

Lecturer: “Depo-Naltrexone after Opiate Reversal under General Anesthesia,” presented at the University of Pennsylvania, Department of Psychiatry, Treatment Research Center Seminar Series, Philadelphia, Pennsylvania, July 28, 1997.

Lecturer: “Heroin Addiction Treatment” presented at American Osteopathic Academy of Addiction Medicine, 102nd Annual AOA Conference and Scientific Seminar, San Antonio, Texas, October 20, 1997.

Lecturer: “DWI and Addiction Medicine Issues” presented at the American Society of Addiction Medicine, Medical Review Officer Forensic Issues in Addiction Medicine Conference, Atlanta, Georgia, February 19, 1998.

Poster Presentation: “Depo-Naltrexone versus Oral Naltrexone Post-Detoxification” presented at the American Society of Addiction Medicine, 29th Annual Medical Scientific Conference, New Orleans, Louisiana, April 17 – 19, 1998.

Lecturer: “Addiction Medicine: A Tool for Early Intervention, Component Session of Forensic Addiction Medicine” presented at the American Society of Addiction Medicine, 29th Annual Medical Scientific Conference, New Orleans, Louisiana, April 17 – 19, 1998.

Lecturer: “Antagonist Assisted Abstinence” presented to the Department of Medicine, West Jersey Health Systems, Voorhees, New Jersey, May 12, 1998.

Lecturer: “Rapid Opiate Detoxification” presented to Camden County Probation Department, Blackwood, New Jersey, November 5, 1998.

Poster Presentation: “Depo-Naltrexone for Protection against Opiate Defect in the Post Detoxification.” Presented at the 9th Annual Meeting and Symposium of the American Academy of Addiction Psychiatry, Amelia, Island, Florida, December 3 – 6, 1998.

Lecturer: “Antagonist Assisted Abstinence” presented to the Poison Control Center, Philadelphia, Pennsylvania, February 29, 2000.

Lecturer: “Rapid Detoxification Techniques” presented to the 11th Annual Clinical Meeting of the American Academy of Pain Management. Las Vegas, Nevada, September 23, 2000.

Lecturer: “An Alternative to Incarceration for Heroin Addicts” presented to Hunterdon County Probation Department, Flemington, New Jersey, October 2, 2001.

Lecturer “Preventing Precipitous Opiate Withdrawal and Antagonist Assisted Abstinence (A3)” Presented to Kennedy Health System, Department of Emergency Medicine, Stratford, New Jersey, November, 2006.

Lecturer: “Preventing Precipitous Opiate Withdrawal and Antagonist Assisted Abstinence (A3)” Presented to Kennedy Health System, Department of Psychiatry, Stratford, New Jersey, January 24, 2007.

Lecturer: “Addiction Law & DWI” presented at American College of Legal Medicine Conference, Orlando, Florida, March 5, 2010.

Lecturer: “Interlock Device” Presented to New Jersey State Bar Association, New Brunswick, New Jersey, March 15, 2010.

Lecturer: “Naltrexone” presented to Drexel University, Division of Toxicology, Department of Emergency Medicine, Philadelphia, Pa., May 4, 2010.

Lecturer: “Paradigm Shift in the Approach to Treatment of Addiction” presented at Grand Rounds – Texas Tech University School of Medicine, October 26, 2010.

Participant, Expert Panel: “Advance DWI Defense”, NJICLE, Newark, New Jersey,
September 29, 2012.

Key Note Speaker: “ Medicine (DSM) vs. NHTSA in DWI Cases – A Comparison of How Real Science Gets Ignored” presented at the 20th Annual Mastering Scientific Evidence in DUI/DWI Cases. New Orleans, Louisiana, March 21, 2013

Lecturer: “Discovery: Field Sobriety Testing and Physiologically Based Defenses” and ” Expert Witnesses: Blood/Breath/Physiology” presented to the 2014 DWI Institute, New Jersey Bar Association, New Brunswick, New Jersey, July 10, 2014

Lecturer: “Cutting Edge Addiction Medicine and Detoxification” presented at the 57th Annual Meeting of American College of Legal Medicine, Las Vegas, Nevada, February 24, 2017.

 

PUBLICATIONS
Rapid Opiate Detoxification, Journal of Addictive Diseases, Volume 15, No. 2 (1996), Abstract 7, p. 117, Lance Gooberman, M.D., Thaddeus Bartter, M.D.

Rapid Opiate Detoxification, American Journal of Drug and Alcohol Abuse, Volume 22, No. 4,
pp. 489-495(1996), Lance Gooberman, M.D., Thaddeus Bartter, M.D.

Rapid Opiate Detoxification and Naltrexone Induction under General Anesthesia and Assisted Ventilation: Experience with 510 Patients in Four Countries, In Press 1996, Acta Psychiatrica Belgica, Colin
Brewer,M.R.C., Psych,Mary Laban, M.R.C.A., Charles Schmulian, F.F.A., Lance Gooberman, M.D., Yiannis Kasvikis,M.R.C.,Psych, Nabil Abdel Maksoud, M.D.

Rapid Opioid Detoxification, Journal of the American Medical Association, Letter to the Editor, Volume 279, No. 23, Page 1871, June 17, 1998, Lance L. Gooberman, M.D.

Using the Diagnostic and Statistical Manual to Raise the NHTSA-Created Low Threshold for Diagnosing Alcohol Intoxication, Understanding DUI Scientific Evidence, 2013 Edition, pp. 271-298, Lance Gooberman, M.D., DABAM and  Ashley E. Killeen, JD

 

 


AWARDS
Benjamin Franklin Emerging Business Award U.S. Detox Center, Merchantville, New Jersey
Most Innovative Service, Philadelphia, Pennsylvania, November 1996


UNITED STATES PATENTS ISSUED
1) Improvement to Rapid Opioid Detoxification
Patent Number 5,789,411
Issued August 4, 1998

2) Rapid Opiate Detoxification
Patent Number 6,004,962
Issued December 21, 1999

3) Pharmaceutical Delivery Device and Method of Preparation Thereof
Patent Number 6,203,813
Issued March 20, 2001

4) Pharmaceutical Delivery Systems for Treatment of Substance Abuse and Other Addictions
Patent Number 8,791,093
Issued July 29, 2014

UNITED STATES PATENTS PENDING

1) Degradable Networks for Sustained Release and Controlled Release Depot Drug Delivery Applications   Polymer Coated Implants – Blocking Plus Aversive Agents

2) Implants Containing Disulfiram and an Anti-Inflammatory Agent                                                                                 Disulfiram Pellets

3) Medicated Spray for Treatment of Addiction and Impulse Control Disorders                                                    Naltrexone Spray

4) Restrictive Cell Phone Use and Anti-Texting Apparatus and Methods                                                                              Anti-Texting Ignition Interlock Device (ATIID)

Revised 7/10/17